FDA investigation of RU-486 death reports
Executive Summary
FDA is "obtaining more information" about a recent death associated with Danco's abortifacient Mifeprex (mifepristone). Since the drug's approval in September 2000, FDA has received three other reports (one each in the U.S., Canada and U.K.) of women who died and were taking mifepristone, but says it is "unlikely that these deaths were caused by" the drug. FDA will "continue to monitor adverse events with this particular drug, as it does with all drugs," the agency says...